2
Clinical Trials associated with KLA578-1A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of KLA578-1 for Injection in Healthy Volunteers
The purpose of this study is to evaluate the safety and tolerability and pharmacokinetics of single and multiple doses of KLA578-1 for injection in healthy volunteers
评价注射用KLA578-1在健康受试者中的单/多次给药的安全性、耐受性及药代动力学特征的Ⅰ期临床研究
[Translation] Phase I clinical study to evaluate the safety, tolerability and pharmacokinetic characteristics of single/multiple administration of KLA578-1 for injection in healthy subjects
主要研究目的:
评价健康受试者单次及多次注射KLA578-1后的安全性和耐受性。
次要研究目的:
评价健康受试者单次及多次注射KLA578-1后的药代动力学特征。
[Translation] Primary study objective:
To evaluate the safety and tolerability of KLA578-1 after single and multiple injections in healthy subjects.
Secondary study objective:
To evaluate the pharmacokinetic characteristics of KLA578-1 after single and multiple injections in healthy subjects.
100 Clinical Results associated with KLA578-1
100 Translational Medicine associated with KLA578-1
100 Patents (Medical) associated with KLA578-1
100 Deals associated with KLA578-1